arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Sonida Senior Living, Inc.

SNDA Health Care Hospital/Nursing Management
$37.69
▼ -0.0% Today
as of Sep 4, 16:54 ET
Last 30 days -11.98% Jul 27 → Sep 04
$37.01 $38.64 $40.26 $41.89 $43.52 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$38.42
High
$39.26
Low
$37.62
Volume
$754,041
Avg Vol
$351,148
Mkt Cap
$1.9B
P/E (TTM)
—
Beta
—
52w High
$44.39
52w Low
$24.95
Div Yield
—
Shares Out
$47M

Recent Press Releases & News last 60 days · 14 items

Sep 4 · 18:13 MT Newswires
Sonida Senior Living Shares Rise After Baird Upgrade
Sep 4 · 11:11 MT Newswires
Baird Upgrades Sonida Senior Living to Outperform From Neutral, Raises Price Target to $43 From $37
Sep 2 · 07:57 MT Newswires
Sonida Senior Living Insider Sold Shares Worth $4,761,783, According to a Recent SEC Filing
▸ Show all 14 press releases & news Free account →

Overview

52-week range
$25
$44
66% of range
Avg surprise (last 3)
+18.4%
Avg reaction (last 2)
+3.2%
50% positive
Latest IV / EM
51%
EM ±8.0% · $40 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.79$-1.40$-0.02$1.37$2.76 Actual $2.76Actual $-2.11Actual $-2.79Actual $2.16Actual $-0.86Actual $-0.98Actual $-0.77Est $-0.95Actual $-0.16Est $-0.78Actual $-1.56Actual $-2.39Est $-1.67Actual $-0.52 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-41M$23M$88M$153M$218M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.52 — — — — financials
Mon May 11, 2026Mar/2026 $-2.39 $-1.67 -43.1% -210.4% -3.4% earnings
Tue Sep 30, 2025Sep 2025 $-1.56 — — — — financials
Mon Aug 11, 2025Jun/2025 $-0.16 $-0.78 +79.5% — — earnings
Mon May 12, 2025Mar/2025 $-0.77 $-0.95 +18.9% — +9.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.98 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.86 — — — — financials
Sun Mar 31, 2024Mar 2024 $2.16 — — — — financials
Sat Sep 30, 2023Sep 2023 $-2.79 — — — — financials
Fri Jun 30, 2023Jun 2023 $-2.11 — — — — financials
Fri Mar 31, 2023Mar 2023 $2.76 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$208M$123M—$98M$94M$92M—$75M
Cost of revenue————————
Gross profit————————
Operating income—————$20M——
Net income$-24M$-41M—$-27M$-2M$-13M—$-14M
EPS (diluted)$-0.52$-2.39—$-1.56$-0.16$-0.77—$-0.98

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$49M$84M$11M$17M$14M$14M$17M$25M
Inventory————————
Total current assets$110M$147M$78M$73M$63M$54M$64M$164M
Total assets$2.55B$2.63B$845M$855M$850M$824M$842M$796M
Long-term debt$1.56B$1.40B$682M$663M$660M$636M$636M$590M
Total liabilities$1.68B$1.74B$789M$768M$736M$709M$712M$660M
Total equity$862M$889M$-11,000$30M$63M$65M$72M$85M

Implied volatility — last 90 days

41%59%78%97%115% Jun 08 — IV 84% · EM ±11.0%Jun 09 — IV 54% · EM ±6.7%Jun 10 — IV 84% · EM ±9.9%Jun 11 — IV 80% · EM ±8.8%Jun 16 — IV 100% · EM ±5.9%Jun 17 — IV 69% · EM ±2.9%Jun 19 — IV 51% · EM ±11.2%Jun 22 — IV 78% · EM ±16.3%Jun 23 — IV 80% · EM ±16.4%Jun 24 — IV 43% · EM ±8.7%Jun 25 — IV 45% · EM ±8.9%Jun 26 — IV 41% · EM ±7.9%Jun 29 — IV 44% · EM ±7.9%Jun 30 — IV 63% · EM ±10.8%Jul 01 — IV 65% · EM ±10.9%Jul 02 — IV 75% · EM ±12.1%Jul 03 — IV 77% · EM ±12.1%Jul 06 — IV 75% · EM ±10.3%Jul 07 — IV 72% · EM ±9.5%Jul 08 — IV 65% · EM ±8.1%Jul 09 — IV 57% · EM ±6.8%Jul 10 — IV 70% · EM ±7.8%Jul 13 — IV 82% · EM ±6.8%Jul 14 — IV 47% · EM ±3.4%Jul 20 — IV 55% · EM ±12.9%Jul 21 — IV 54% · EM ±12.6%Jul 22 — IV 60% · EM ±13.7%Jul 23 — IV 54% · EM ±12.1%Jul 24 — IV 52% · EM ±11.6%Jul 27 — IV 54% · EM ±11.2%Jul 28 — IV 65% · EM ±13.2%Jul 29 — IV 60% · EM ±12.1%Jul 30 — IV 65% · EM ±12.7%Jul 31 — IV 63% · EM ±12.1%Aug 03 — IV 64% · EM ±11.3%Aug 04 — IV 69% · EM ±11.8%Aug 05 — IV 68% · EM ±11.4%Aug 06 — IV 66% · EM ±10.7%Aug 07 — IV 68% · EM ±10.6%Aug 10 — IV 69% · EM ±9.6%Aug 11 — IV 44% · EM ±5.8%Aug 12 — IV 50% · EM ±6.2%Aug 13 — IV 48% · EM ±5.7%Aug 17 — IV 83% · EM ±6.9%Aug 18 — IV 84% · EM ±6.1%Aug 19 — IV 65% · EM ±3.8%Aug 20 — IV 116% · EM ±4.8%Aug 24 — IV 44% · EM ±9.1%Aug 25 — IV 51% · EM ±10.4%Aug 26 — IV 42% · EM ±8.5%Aug 27 — IV 43% · EM ±8.5%Aug 28 — IV 103% · EM ±19.8%Aug 31 — IV 59% · EM ±10.5%Sep 01 — IV 79% · EM ±13.6%Sep 02 — IV 63% · EM ±10.5%Sep 03 — IV 53% · EM ±8.6%Sep 04 — IV 51% · EM ±8.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in